Trials / Not Yet Recruiting
Not Yet RecruitingNCT06715020
Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to construct a noninvasive approach 68Ga-TTP PET/CT to detect the TROP2 expression of tumor lesions in patients with breast tumors and evaluate the efficacy of ADC drug therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-FDG | All study participants will undergo one 18F-FDG PET scan. |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2024-12-04
- Last updated
- 2024-12-04
Source: ClinicalTrials.gov record NCT06715020. Inclusion in this directory is not an endorsement.